During the past decade, Yokohama Municipal Citizen's Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 10 clinical trials were completed, i.e. on average, 47.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yokohama Municipal Citizen's Hospital" #1 sponsor was "Japan Clinical Oncology Group" with 3 trials, followed by "Takeda" with 3 trials sponsored, "BeiGene" with 2 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yokohama Municipal Citizen's Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator, "BeiGene" with 1 trials as a collaborator and "Japanese Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Yokohama Municipal Citizen's Hospital" are "COVID-19" (3 trials), "Short Bowel Syndrome" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Colorectal Cancer" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Yokohama Municipal Citizen's Hospital" in a lesser frequency.

Most popular intervention types in "Yokohama Municipal Citizen's Hospital" are "Drug" (25 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Guselkumab" (2 trials), "Needle" (2 trials), "Remdesivir" (2 trials) and "Standard of Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Yokohama Municipal Citizen's Hospital" are 27 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yokohama Municipal Citizen's Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Yokohama Municipal Citizen's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Yokohama Municipal Citizen's Hospital, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Yokohama Municipal Citizen's Hospital has several departments that took part in Clinical trials: "Kanagawa Cancer Center - Dept of Respiratory Medicine" - 2 trials